What you need to know about the status of the proposed EMA fees regulation

The European Commission has proposed a regulation to revise the fees regulation governing the cost of compensating the European Medicines Agency (EMA) for its regulatory activities, with the aim of streamlining the fee structure and increasing fees in line with the cost of services and inflation. The still-pending agreement seems likely to soon be adopted, which would trigger an application date of January 1, 2025.

Fill out the form to read the full article.

Required *

Copy link
Powered by Social Snap